LobbyingBiomerieux lobbying by quarter
Biomerieux's latest lobbying report covers Q2 2026, at $240K. The four quarters Q3 2025–Q2 2026 total $1.1M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Food Industry (Safety, Labeling, etc.).
Biomerieux
- Latest quarter
- $240K
- Q2 2026 · 3 reports
- Last 12 months
- $1.1M
- Last 4 quarters
- vs last quarter
- −11.1%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $5,000 | 1 |
| Q1 2023 | $5,000 | 1 |
| Q2 2023 | $5,000 | 1 |
| Q3 2023 | $5,000 | 1 |
| Q4 2023 | $5,000 | 1 |
| Q1 2024 | $15K | 2 |
| Q2 2024 | $85K | 3 |
| Q3 2024 | $305K | 4 |
| Q4 2024 | $295K | 4 |
| Q1 2025 | $300K | 4 |
| Q2 2025 | $425K | 5 |
| Q3 2025 | $380K | 4 |
| Q4 2025 | $230K | 3 |
| Q1 2026 | $270K | 3 |
| Q2 2026 | $240K | 3 |
Policy issues the reports name
- Health issues21 reports
- Food industry11 reports
- Budget and appropriations8 reports
- Medical research and clinical labs8 reports
- Tariffs6 reports
- Medicare and Medicaid5 reports
- Trade5 reports
- Taxation3 reports
- Pharmacy1 reports
- Manufacturing1 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE31 reports
- HOUSE OF REPRESENTATIVES29 reports
- Agriculture, Dept of (USDA)7 reports
- Veterans Affairs, Dept of (VA)6 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Food & Drug Administration (FDA)4 reports
- Health & Human Services, Dept of (HHS)3 reports
- Office of Management & Budget (OMB)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBiomerieux | $1.7M | 8 quarters |
| Alston & Bird | $310K | 5 quarters |
| BGR Government Affairs | $250K | 6 quarters |
| Ballard Partners | $220K | 6 quarters |
| Groundswell Strategy | $70K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CARMEN ROTTENBERG | Administrator, USDA FSIS | Q2 2026 |
| JEFF MILLER | Former Member U.S. Congress | Q3 2025 |
| MICHAEL PARK | Health Policy Counsel, Senate Finance Committee. | Q3 2025 |
| ANNA OSTERLIND JONES | USDA, Trade & For. Ag. Aff., Chief of Staff; USDA, Ag.Mark. Serv., Chief of Staff; USDA, Off. of Cong. Relations,Cong. & Policy Adv.; Sen. Blunt: Leg. Corr., Exec. Assistantto Chief of Staff, Staff Assistant, Intern; House BudgetComm., Intern | Q2 2025 |
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q1 2025 |
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q1 2025 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q1 2025 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q1 2025 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q1 2025 |
| RYAN LONG | Senior Policy and Counsel, Speaker Kevin McCarthy; Senior Policy Advisor and Counsel, Minority Leader Kevin McCarthy; Deputy Staff Director and Staff Director, House Energy and Commerce Committee; LC, Rep Norwood; LA & LD, Rep Barton | Q1 2025 |
| JOHN RICHTER | 2009-2014 -Office of Sen. Robert Casey; 2014-2017-0ffice of Congresswoman Michelle Lujan Grisham | Q3 2024 |
| PAUL HARTMAN | 12/2015-1/2018-LA-Rep.Tim Murphy; 1/2018-1/2019-LA-Rep.Tom Garrett Jr.; 1/2019-3/2019-House Energy and Commerce Health Subcommittee; HHS Policy Advisor 3/2019-10/2019; 10/2019-8/2024-Policy Advisor Rep. Bob Latta | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $160K |
| 07/20for Q2 | Alston & Bird | $70K |
| 07/20for Q2 | Groundswell Strategy | $10K |
| 04/20for Q1 | In-house | $190K |
| 04/20for Q1 | Groundswell Strategy | $10K |
| 04/20for Q1 | Alston & Bird | $70K |
| 01/20for Q4 2025 | In-house | $160K |
| 01/20for Q4 2025 | Alston & Bird | $70K |
| 01/20for Q4 2025 | Groundswell Strategy | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | $290K |
| 25/10/20for Q3 2025 | Alston & Bird | $70K |
| 25/10/16for Q3 2025 | Ballard Partners | $20K |
| 25/10/15for Q3 2025 | Groundswell Strategy | Under $5,000 |
| 25/07/21for Q2 2025 | Alston & Bird | $30K |
| 25/07/21for Q2 2025 | Groundswell Strategy | $5,000 |
| 25/07/21for Q2 2025 | BGR Government Affairs | Under $5,000 |
| 25/07/21for Q2 2025 | Ballard Partners | $50K |
| 25/07/21for Q2 2025 | Alston & Bird | Under $5,000 |
| 25/07/18for Q2 2025 | In-house | $340K |
| 25/04/21for Q1 2025 | Groundswell Strategy | Under $5,000 |